GDI marks milestones and plans for 2024
In a two-day General Assembly, the European Genomic Data Infrastructure (GDI) discussed the achievements of its first year and outlined plans for the next year. It was highlighted that the European Health Data Space (EHDS), the European 1+ Million Genomes (1+MG) initiative, and the EUropean Federation for CAncer IMages (EUCAIM) should leverage the GDI infrastructure. GDI should develop into a support system for decision-making in healthcare, for which national and node-level arrangements are essential. The participating countries were encouraged to provide feedback on data availability before the Genome of Europe (GoE) project submission during the week of November 20-24.
Looking ahead to 2024, GDI is set to deploy its infrastructure using synthetic data at vanguard nodes to test functionality, while the European-level legal framework is approved. In detail, this includes linking the user portal and data capture, defining metadata to allow data searches across national data portals, and supporting federated analysis. The assembly concluded by announcing the release of the "1+MG Framework and Roadmap 2023-2027".
GHGA, serving as the GDI node for Germany and actively participated in discussions both on infrastructure deployment (Pillar II) and the cancer, infectious diseases, and rare diseases use cases (Pillar III) during the General Assembly.